Formosa Laboratories
Formosa Laboratories, also known as Formosa, is a leading player in the pharmaceutical and biotechnology industry, headquartered in Taiwan (TW). Founded in 1996, the company has established a strong presence in key operational regions, including North America and Europe, focusing on the development and manufacturing of high-quality active pharmaceutical ingredients (APIs) and intermediates. With a commitment to innovation, Formosa Laboratories offers a diverse range of products and services, including custom synthesis and contract manufacturing. Their unique approach combines advanced technology with stringent quality control, ensuring compliance with global regulatory standards. Recognised for its expertise, Formosa has achieved significant milestones, positioning itself as a trusted partner in the pharmaceutical supply chain.
DitchCarbon Score
How does Formosa Laboratories's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Formosa Laboratories's score of 58 is higher than 93% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Formosa Laboratories's reported carbon emissions
In 2023, Formosa Laboratories reported total carbon emissions of approximately 13,315,000 kg CO2e. This figure includes Scope 1 emissions of about 3,646,000 kg CO2e, Scope 2 emissions of approximately 9,669,000 kg CO2e, and Scope 3 emissions, which encompass various categories such as employee commute (about 5,298,000 kg CO2e) and purchased goods and services (approximately 11,757,257 kg CO2e). The company has set ambitious climate commitments, aiming for a 51% absolute reduction in emissions across Scopes 1 and 2 by 2030, using 2018 as the baseline year. Additionally, Formosa Laboratories targets a 15% reduction in emissions from purchased goods and services within Scope 3 by the same year. These initiatives align with their long-term goal of achieving net-zero emissions by 2050, as part of their commitment to sustainable management and greenhouse gas reduction. Formosa Laboratories has been actively conducting greenhouse gas inventories since 2021, in line with governmental policies and global carbon reduction trends. The company continues to promote energy conservation and emission reduction strategies to fulfil its corporate responsibilities.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2018 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|
| Scope 1 | - | 000,000 | 0,000,000.0 | 0,000,000 |
| Scope 2 | 73,826,000 | 00,000,000 | 00,000,000 | 0,000,000 |
| Scope 3 | 168,124,000 | - | 00,000,000 | 00,000,000.0 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Formosa Laboratories is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
